Levels of Circulating TIMP-2 and MMP2-TIMP2 Complex Are Decreased in Squamous Cervical Carcinoma

por Anne, Talvensaari-Mattila, Taina, Turpeenniemi-Hujanen
Publicado 2010

Matrix metalloproteinase-2 (MMP-2) is associated with survival in breast carcinoma

por Talvensaari-Mattila, A, Pääkkö, P, Turpeenniemi-Hujanen, T
Publicado 2003

The Sample Type used Affects the Levels of Gelatinases (MMP-2 and -9) and their Inhibitors (TIMP-1 and -2) in Circulating Blood of Healthy Controls and Breast Cancer Patients

por Paula, Kuvaja, Anne, Talvensaari-Mattila, Taina, Turpeenniemi-Hujanen
Publicado 2007

Significance of bulky mass and residual tumor—Treated with or without consolidative radiotherapy—To the risk of relapse in DLBCL patients

por Tokola, Susanna, Kuitunen, Hanne, Turpeenniemi‐Hujanen, Taina, Kuittinen, Outi
Publicado 2020

Interim and end‐of‐treatment PET‐CT suffers from high false‐positive rates in DLBCL: Biopsy is needed prior to treatment decisions

por Tokola, Susanna, Kuitunen, Hanne, Turpeenniemi‐Hujanen, Taina, Kuittinen, Outi
Publicado 2021

Combination of Strong MMP-2 and Weak TIMP-2 Immunostainings Is a Significant Prognostic Factor in Endometrial Carcinoma

por Honkavuori-Toivola, Maria, Santala, Markku, Soini, Ylermi, Turpeenniemi-Hujanen, Taina, Talvensaari-Mattila, Anne
Publicado 2013

p53 in head and neck cancer: Functional consequences and environmental implications of TP53 mutations

por Peltonen, Jenni K, Helppi, Henni M, Pääkkö, Paavo, Turpeenniemi-Hujanen, Taina, Vähäkangas, Kirsi H
Publicado 2010

Circulating matrix metalloproteinase MMP-9 and MMP-2/TIMP-2 complex are associated with spontaneous early pregnancy failure

por Nissi, Ritva, Talvensaari-Mattila, Anne, Kotila, Vesa, Niinimäki, Maarit, Järvelä, Ilkka, Turpeenniemi-Hujanen, Taina
Publicado 2013

Specific TP53 mutations predict aggressive phenotype in head and neck squamous cell carcinoma: a retrospective archival study

por Peltonen, Jenni K, Vähäkangas, Kirsi H, Helppi, Henni M, Bloigu, Risto, Pääkkö, Paavo, Turpeenniemi-Hujanen, Taina
Publicado 2011

p53 immunohistochemistry in transitional cell carcinoma and dysplasia of the urinary bladder correlates with disease progression.

por Soini, Y., Turpeenniemi-Hujanen, T., Kamel, D., Autio-Harmainen, H., Risteli, J., Risteli, L., Nuorva, K., Pääkkö, P., Vähäkangas, K.
Publicado 1993

Snail promotes an invasive phenotype in lung carcinoma

por Merikallio, Heta, Turpeenniemi-Hujanen, Taina, Pääkkö, Paavo, Mäkitaro, Riitta, Riitta, Kaarteenaho, Salo, Sirpa, Salo, Tuula, Harju, Terttu, Soini, Ylermi
Publicado 2012

Antithrombin III is probably not a suitable biomarker for diagnosis of primary central nervous system lymphoma

por Kuusisto, Milla Elvi Linnea, Haapasaari, Kirsi-Maria, Remes, Anne Marja, Bloigu, Risto, Karihtala, Peeter, Turpeenniemi-Hujanen, Taina, Kuittinen, Outi
Publicado 2015

Primary central nervous system lymphoma high incidence and poor survival in Finnish population-based analysis

por Puhakka, Inka, Kuitunen, Hanne, Jäkälä, Pekka, Sonkajärvi, Eila, Turpeenniemi-Hujanen, Taina, Rönkä, Aino, Selander, Tuomas, Korhonen, Miika, Kuittinen, Outi
Publicado 2022

Long-term prognosis of breast cancer detected by mammography screening or other methods

por Lehtimäki, Tiina, Lundin, Mikael, Linder, Nina, Sihto, Harri, Holli, Kaija, Turpeenniemi-Hujanen, Taina, Kataja, Vesa, Isola, Jorma, Joensuu, Heikki, Lundin, Johan
Publicado 2011

Impact of central nervous system (CNS) prophylaxis on the incidence of CNS relapse in patients with high-risk diffuse large B cell/follicular grade 3B lymphoma

por Kuitunen, Hanne, Kaprio, Elina, Karihtala, Peeter, Makkonen, Ville, Kauppila, Saila, Haapasaari, Kirsi-Maria, Kuusisto, Milla, Jantunen, Esa, Turpeenniemi-Hujanen, Taina, Kuittinen, Outi
Publicado 2020

Development and evaluation of a virtual microscopy application for automated assessment of Ki-67 expression in breast cancer

por Konsti, Juho, Lundin, Mikael, Joensuu, Heikki, Lehtimäki, Tiina, Sihto, Harri, Holli, Kaija, Turpeenniemi-Hujanen, Taina, Kataja, Vesa, Sailas, Liisa, Isola, Jorma, Lundin, Johan
Publicado 2011

Oxidative stress and redox state-regulating enzymes have prognostic relevance in diffuse large B-cell lymphoma

por Peroja, Pekka, Pasanen, Anna Kaisa, Haapasaari, Kirsi-Maria, Jantunen, Esa, Soini, Ylermi, Turpeenniemi-Hujanen, Taina, Bloigu, Risto, Lilja, Laura, Kuittinen, Outi, Karihtala, Peeter
Publicado 2012

Breast cancer biological subtypes and protein expression predict for the preferential distant metastasis sites: a nationwide cohort study

por Sihto, Harri, Lundin, Johan, Lundin, Mikael, Lehtimäki, Tiina, Ristimäki, Ari, Holli, Kaija, Sailas, Liisa, Kataja, Vesa, Turpeenniemi-Hujanen, Taina, Isola, Jorma, Heikkilä, Päivi, Joensuu, Heikki
Publicado 2011

Nuclear factor erythroid 2-related factors 1 and 2 are able to define the worst prognosis group among high-risk diffuse large B cell lymphomas treated with R-CHOEP

por Kari, Esa, Teppo, Hanna-Riikka, Haapasaari, Kirsi-Maria, Kuusisto, Milla Elvi Linnea, Lemma, Aurora, Karihtala, Peeter, Pirinen, Risto, Soini, Ylermi, Jantunen, Esa, Turpeenniemi-Hujanen, Taina, Kuittinen, Outi
Publicado 2019

Docetaxel versus docetaxel alternating with gemcitabine as treatments of advanced breast cancer: final analysis of a randomised trial

por Joensuu, H., Sailas, L., Alanko, T., Sunela, K., Huuhtanen, R., Utriainen, M., Kokko, R., Bono, P., Wigren, T., Pyrhönen, S., Turpeenniemi-Hujanen, T., Asola, R., Leinonen, M., Hahka-Kemppinen, M., Kellokumpu-Lehtinen, P.
Publicado 2010